Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Cardiovascular Disease Risk Prediction in the HIV Outpatient Study.

Thompson-Paul AM, Lichtenstein KA, Armon C, Palella FJ Jr, Skarbinski J, Chmiel JS, Hart R, Wei SC, Loustalot F, Brooks JT, Buchacz K.

Clin Infect Dis. 2016 Dec 1;63(11):1508-1516. Epub 2016 Sep 9.

PMID:
27613562
2.

High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy.

Escota GV, Mondy K, Bush T, Conley L, Brooks JT, Önen N, Patel P, Kojic EM, Henry K, Hammer J, Wood KC, Lichtenstein KA, Overton ET.

AIDS Res Hum Retroviruses. 2016 Jan;32(1):59-67. doi: 10.1089/aid.2015.0158. Epub 2015 Sep 14.

PMID:
26366785
3.

Statin Use Is Associated With Incident Diabetes Mellitus Among Patients in the HIV Outpatient Study.

Lichtenstein KA, Hart RL, Wood KC, Bozzette S, Buchacz K, Brooks JT; HIV Outpatient Study Investigators..

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):306-11. doi: 10.1097/QAI.0000000000000581.

4.

Trends in use of genotypic resistance testing and frequency of major drug resistance among antiretroviral-naive persons in the HIV Outpatient Study, 1999-2011.

Buchacz K, Young B, Palella FJ Jr, Armon C, Brooks JT; HIV Outpatient Study (HOPS) investigators.; HIV Outpatient Study HOPS investigators..

J Antimicrob Chemother. 2015 Aug;70(8):2337-46. doi: 10.1093/jac/dkv120. Epub 2015 May 15.

PMID:
25979729
5.

Disparities in Initiation of Combination Antiretroviral Treatment and in Virologic Suppression Among Patients in the HIV Outpatient Study, 2000-2013.

Novak RM, Hart RL, Chmiel JS, Brooks JT, Buchacz K; HIV Outpatient Study (HOPS) Investigators..

J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):23-32. doi: 10.1097/QAI.0000000000000652.

PMID:
25886926
6.

Seasonal influenza vaccination rates in the HIV outpatient study-United States, 1999-2013.

Durham MD, Buchacz K, Armon C, Patel P, Wood K, Brooks JT; HIV Outpatient Study (HOPS) Investigators..

Clin Infect Dis. 2015 Mar 15;60(6):976-7. doi: 10.1093/cid/ciu979. Epub 2014 Dec 11. No abstract available.

PMID:
25501987
7.

Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).

Palella FJ Jr, Armon C, Buchacz K, Chmiel JS, Novak RM, D'Aquila RT, Brooks JT; HOPS Investigators..

J Antimicrob Chemother. 2014 Oct;69(10):2826-34. doi: 10.1093/jac/dku190. Epub 2014 Jun 16.

PMID:
24942257
8.

Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?

Yangco BG, Buchacz K, Baker R, Palella FJ, Armon C, Brooks JT; HIV Outpatient Study Investigators..

AIDS Patient Care STDS. 2014 Jun;28(6):280-3. doi: 10.1089/apc.2013.0270. Epub 2014 May 15.

9.

Retention in care within 1 year of initial HIV care visit in a multisite US cohort: who's in and who's out?

Tedaldi EM, Richardson JT, Debes R, Young B, Chmiel JS, Durham MD, Brooks JT, Buchacz K; HOPS Investigators..

J Int Assoc Provid AIDS Care. 2014 May-Jun;13(3):232-41. doi: 10.1177/2325957413514631. Epub 2014 Feb 3.

10.

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.

Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJ, Nguyen BY, Teppler H; BENCHMRK Study Teams..

Lancet Infect Dis. 2013 Jul;13(7):587-96. doi: 10.1016/S1473-3099(13)70093-8. Epub 2013 May 7.

PMID:
23664333
11.

Sexual risk behavior and viremia among men who have sex with men in the HIV Outpatient Study, United States, 2007-2010.

Durham MD, Buchacz K, Richardson J, Yang D, Wood K, Yangco B, Brooks JT; HOPS Investigators..

J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):372-8. doi: 10.1097/QAI.0b013e31828c20d8.

PMID:
23422850
12.

Provider compliance with guidelines for management of cardiovascular risk in HIV-infected patients.

Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Buckner K, Tedaldi E, Wood K, Holmberg SD, Brooks JT; HOPS Investigators..

Prev Chronic Dis. 2013;10:E10. doi: 10.5888/pcd10.120083.

13.

Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US.

Buchacz K, Baker RK, Palella FJ Jr, Shaw L, Patel P, Lichtenstein KA, Chmiel JS, Vellozzi C, Debes R, Henry K, Overton ET, Bush TJ, Tedaldi E, Carpenter C, Mayer KH, Brooks JT; HIV Outpatient Study Investigators..

Antivir Ther. 2013;18(1):65-75. doi: 10.3851/IMP2450. Epub 2012 Oct 30.

PMID:
23111762
14.

A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.

Lichtenstein KA, Armon C, Nagabhushanam V, Efaw BJ, Frazer-Abel A, Hiserote ME, Alam R.

Antivir Ther. 2012;17(7):1301-9. doi: 10.3851/IMP2350. Epub 2012 Sep 5.

PMID:
22948290
15.

Immune reconstitution inflammatory syndrome: incidence and implications for mortality.

Novak RM, Richardson JT, Buchacz K, Chmiel JS, Durham MD, Palella FJ, Wendrow A, Wood K, Young B, Brooks JT; HIV Outpatient Study (HOPS) Investigators..

AIDS. 2012 Mar 27;26(6):721-30. doi: 10.1097/QAD.0b013e3283511e91.

16.

Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment.

Palella FJ Jr, Baker RK, Buchacz K, Chmiel JS, Tedaldi EM, Novak RM, Durham MD, Brooks JT; HOPS Investigators..

AIDS. 2011 Sep 24;25(15):1865-76. doi: 10.1097/QAD.0b013e32834b3537.

PMID:
21811144
17.

Rates and correlates of influenza vaccination among HIV-infected adults in the HIV Outpatient Study (HOPS), USA, 1999-2008.

Durham MD, Buchacz K, Armon C, Patel P, Wood K, Brooks JT; HOPS Investigators..

Prev Med. 2011 Jul-Aug;53(1-2):89-94. doi: 10.1016/j.ypmed.2011.04.015. Epub 2011 May 4.

PMID:
21569791
18.

Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.

Young B, Dao CN, Buchacz K, Baker R, Brooks JT; HIV Outpatient Study (HOPS) Investigators..

Clin Infect Dis. 2011 Apr 15;52(8):1061-8. doi: 10.1093/cid/ciq242. Epub 2011 Mar 10.

PMID:
21398272
19.

Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.

Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Buckner K, Tedaldi EM, Wood K, Holmberg SD, Brooks JT; HIV Outpatient Study (HOPS) Investigators..

Clin Infect Dis. 2010 Aug 15;51(4):435-47. doi: 10.1086/655144.

PMID:
20597691
20.

AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.

Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM, Wood KC, Brooks JT; HOPS Investigators..

AIDS. 2010 Jun 19;24(10):1549-59. doi: 10.1097/QAD.0b013e32833a3967.

PMID:
20502317

Supplemental Content

Loading ...
Support Center